Search results
Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower
Investor's Business Daily· 2 days agoAnalysts expect $130 million in Leqembi sales this year growing to $455 million in 2025 and $1...
Eli Lilly Pushes Alzheimer's Stocks Lower On FDA Win
Investor's Business Daily· 2 days agoDespite the stock move, analysts largely expect donanemab to gain FDA approval. Late Monday, the advisors to the FDA voted unanimously that the clinical...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 2 days agoLilly plans to bolster its production of diabetes and weight-loss drugs later this year. The company...
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive via Yahoo Finance· 4 days agoThe company came somewhat close years ago with a similar drug called solanezumab, though clinical...
Celestica (CLS) Is Attractively Priced Despite Fast-paced Momentum
Zacks· 7 days agoMomentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid ...
US FDA advisers to review Eli Lilly Alzheimer's drug
Reuters· 4 days agoBoth drugs are designed to remove toxic beta amyloid plaques from the brains of people with early Alzheimer's disease. The antibody treatments, which...
Forget Nvidia: Wall Street Is Very Bullish on Another Unstoppable Artificial Intelligence (AI) Stock...
The Motley Fool· 6 days agoThe company has added $2.5 trillion to its valuation in that time, thanks entirely to red-hot demand...
Gabelli Funds LLC Reduces Holdings in Semler Scientific, Inc. (NASDAQ:SMLR)
ETF DAILY NEWS· 4 days agoGabelli Funds LLC lowered its position in shares of Semler Scientific, Inc. (NASDAQ:SMLR – Free Report) by 9.0% in the fourth quarter, according to its most recent filing with the Securities ...
Salesforce: A Great Opportunity After the Sell-Off
GuruFocus.com via Yahoo Finance· 2 days agoThe company's reputation for exceeding expectations weighed heavily on it. However, I believe the massive post-earnings sell-off may have connotations of...
Upstart stock price could crash 45%: BTIG analyst warns
Invezz· 6 days agoUpstart (NASDAQ: UPST) stock price is down more than 5.0% on Friday after a BTIG analyst issued a...